Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a shorter catheter reduce infections and clots?

NCT ID NCT06884176

Not yet recruiting Knowledge-focused Sponsor: Albert Einstein College of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two types of catheters—midline and central—in 100 adults who need a single vasopressor medication. The goal is to see if the shorter midline catheter leads to fewer bloodstream infections and blood clots. Participants will be randomly assigned to one catheter type and followed for 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If midline catheters cause fewer infections and blood clots, hospitals may switch to using them more often, improving patient safety.
What could go wrong
This is a small, early-stage study (100 patients) at one hospital, so results may not apply everywhere. The catheters are already in use, so no major new risks are expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL VENOUS CATHETER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL VENOUS CATHETER COMPLICATION OF CATHETER MIDLINE CATHETER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Jacobi Medical Center

    The Bronx, New York, 10461, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.